423 related articles for article (PubMed ID: 37619764)
1. The Safety and Antiaging Effects of Nicotinamide Mononucleotide in Human Clinical Trials: an Update.
Song Q; Zhou X; Xu K; Liu S; Zhu X; Yang J
Adv Nutr; 2023 Nov; 14(6):1416-1435. PubMed ID: 37619764
[TBL] [Abstract][Full Text] [Related]
2. Nicotinamide mononucleotide (NMN) as an anti-aging health product - Promises and safety concerns.
Nadeeshani H; Li J; Ying T; Zhang B; Lu J
J Adv Res; 2022 Mar; 37():267-278. PubMed ID: 35499054
[TBL] [Abstract][Full Text] [Related]
3. The role of nicotinamide mononucleotide (NMN) in anti-aging, longevity, and its potential for treating chronic conditions.
Soma M; Lalam SK
Mol Biol Rep; 2022 Oct; 49(10):9737-9748. PubMed ID: 35441939
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of long-term nicotinamide mononucleotide supplementation on metabolism, sleep, and nicotinamide adenine dinucleotide biosynthesis in healthy, middle-aged Japanese men.
Yamaguchi S; Irie J; Mitsuishi M; Uchino Y; Nakaya H; Takemura R; Inagaki E; Kosugi S; Okano H; Yasui M; Tsubota K; Hayashi K; Yoshino J; Itoh H
Endocr J; 2024 Feb; 71(2):153-169. PubMed ID: 38191197
[TBL] [Abstract][Full Text] [Related]
5. Nicotinamide adenine dinucleotide metabolism and arterial stiffness after long-term nicotinamide mononucleotide supplementation: a randomized, double-blind, placebo-controlled trial.
Katayoshi T; Uehata S; Nakashima N; Nakajo T; Kitajima N; Kageyama M; Tsuji-Naito K
Sci Rep; 2023 Feb; 13(1):2786. PubMed ID: 36797393
[TBL] [Abstract][Full Text] [Related]
6. Towards personalized nicotinamide mononucleotide (NMN) supplementation: Nicotinamide adenine dinucleotide (NAD) concentration.
Kuerec AH; Wang W; Yi L; Tao R; Lin Z; Vaidya A; Pendse S; Thasma S; Andhalkar N; Avhad G; Kumbhar V; Maier AB
Mech Ageing Dev; 2024 Apr; 218():111917. PubMed ID: 38430946
[TBL] [Abstract][Full Text] [Related]
7. Nicotinamide mononucleotide supplementation protects the intestinal function in aging mice and D-galactose induced senescent cells.
Ru M; Wang W; Zhai Z; Wang R; Li Y; Liang J; Kothari D; Niu K; Wu X
Food Funct; 2022 Jul; 13(14):7507-7519. PubMed ID: 35678708
[TBL] [Abstract][Full Text] [Related]
8. The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial.
Yi L; Maier AB; Tao R; Lin Z; Vaidya A; Pendse S; Thasma S; Andhalkar N; Avhad G; Kumbhar V
Geroscience; 2023 Feb; 45(1):29-43. PubMed ID: 36482258
[TBL] [Abstract][Full Text] [Related]
9. MIB-626, an Oral Formulation of a Microcrystalline Unique Polymorph of β-Nicotinamide Mononucleotide, Increases Circulating Nicotinamide Adenine Dinucleotide and its Metabolome in Middle-Aged and Older Adults.
Pencina KM; Lavu S; Dos Santos M; Beleva YM; Cheng M; Livingston D; Bhasin S
J Gerontol A Biol Sci Med Sci; 2023 Jan; 78(1):90-96. PubMed ID: 35182418
[TBL] [Abstract][Full Text] [Related]
10. β-Nicotinamide mononucleotide activates NAD+/SIRT1 pathway and attenuates inflammatory and oxidative responses in the hippocampus regions of septic mice.
Li HR; Liu Q; Zhu CL; Sun XY; Sun CY; Yu CM; Li P; Deng XM; Wang JF
Redox Biol; 2023 Jul; 63():102745. PubMed ID: 37201414
[TBL] [Abstract][Full Text] [Related]
11. Nicotinamide mononucleotide inhibits oxidative stress-induced damage in a SIRT1/NQO-1-dependent manner.
Nakajo T; Kitajima N; Katayoshi T; Tsuji-Naito K
Toxicol In Vitro; 2023 Dec; 93():105683. PubMed ID: 37640247
[TBL] [Abstract][Full Text] [Related]
12. Nicotinamide mononucleotide pretreatment improves long-term isoflurane anesthesia-induced cognitive impairment in mice.
Xu J; Chen X; Liu S; Wei Z; Xu M; Jiang L; Han X; Peng L; Gu X; Xia T
Behav Brain Res; 2024 Feb; 458():114738. PubMed ID: 37931707
[TBL] [Abstract][Full Text] [Related]
13. Effect of oral administration of nicotinamide mononucleotide on clinical parameters and nicotinamide metabolite levels in healthy Japanese men.
Irie J; Inagaki E; Fujita M; Nakaya H; Mitsuishi M; Yamaguchi S; Yamashita K; Shigaki S; Ono T; Yukioka H; Okano H; Nabeshima YI; Imai SI; Yasui M; Tsubota K; Itoh H
Endocr J; 2020 Feb; 67(2):153-160. PubMed ID: 31685720
[TBL] [Abstract][Full Text] [Related]
14. Enhancing the biosynthesis of nicotinamide mononucleotide in Lactococcus lactis by heterologous expression of FtnadE.
Kong LH; Liu TY; Yao QS; Zhang XH; Xu WN; Qin JY
J Sci Food Agric; 2023 Jan; 103(1):450-456. PubMed ID: 36205212
[TBL] [Abstract][Full Text] [Related]
15. Reversal of endothelial dysfunction by nicotinamide mononucleotide via extracellular conversion to nicotinamide riboside.
Mateuszuk Ł; Campagna R; Kutryb-Zając B; Kuś K; Słominska EM; Smolenski RT; Chlopicki S
Biochem Pharmacol; 2020 Aug; 178():114019. PubMed ID: 32389638
[TBL] [Abstract][Full Text] [Related]
16. Nicotinamide mononucleotide alters body composition and ameliorates metabolic disorders induced by a high-fat diet.
Zhang Y; Zhu W; Wang M; Xi P; Wang H; Tian D
IUBMB Life; 2023 Jun; 75(6):548-562. PubMed ID: 36785893
[TBL] [Abstract][Full Text] [Related]
17. Technology and functional insights into the nicotinamide mononucleotide for human health.
Liu Y; Gong JS; Marshall G; Su C; Shi JS; Xu ZH
Appl Microbiol Biotechnol; 2023 Aug; 107(15):4759-4775. PubMed ID: 37347262
[TBL] [Abstract][Full Text] [Related]
18. Nicotinamide mononucleotide (NMN) intake increases plasma NMN and insulin levels in healthy subjects.
Yamane T; Imai M; Bamba T; Uchiyama S
Clin Nutr ESPEN; 2023 Aug; 56():83-86. PubMed ID: 37344088
[TBL] [Abstract][Full Text] [Related]
19. Long-Term Administration of Nicotinamide Mononucleotide Mitigates Age-Associated Physiological Decline in Mice.
Mills KF; Yoshida S; Stein LR; Grozio A; Kubota S; Sasaki Y; Redpath P; Migaud ME; Apte RS; Uchida K; Yoshino J; Imai SI
Cell Metab; 2016 Dec; 24(6):795-806. PubMed ID: 28068222
[TBL] [Abstract][Full Text] [Related]
20. A Narrative Review of Nicotinamide Adenine Dinucleotide (NAD)+ Intermediates Nicotinamide Riboside and Nicotinamide Mononucleotide for Keratinocyte Carcinoma Risk Reduction.
Kahn B; Borrelli M; Libby T
J Drugs Dermatol; 2022 Oct; 21(10):1129-1132. PubMed ID: 36219044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
